Aprea Therapeutics (NASDAQ:APRE) reported its Q4 earnings results on Tuesday, March 26, 2024 at 07:45 AM.
Here's what investors need to know about the announcement.
Earnings
Aprea Therapeutics missed estimated earnings by -19.0%, reporting an EPS of $-0.92 versus an estimate of $-0.77.
Revenue was up $14 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.3 which was followed by a 5.0% drop in the share price the next day.
** Listen to the earnings announcement yourself by clicking here. **
To track all earnings releases for Aprea Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.